- Home
- DNTH vs DXPE Comparison
DNTH vs DXPE Comparison
Compare DNTH & DXPE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- DXPE
- Stock Information
- Founded
- DNTH 2015
- DXPE 1908
- Country
- DNTH United States
- DXPE United States
- Employees
- DNTH N/A
- DXPE N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- DXPE Industrial Machinery/Components
- Sector
- DNTH Health Care
- DXPE Industrials
- Exchange
- DNTH Nasdaq
- DXPE Nasdaq
- Market Cap
- DNTH 823.1M
- DXPE 795.0M
- IPO Year
- DNTH N/A
- DXPE 1996
- Fundamental
- Price
- DNTH $20.27
- DXPE $69.12
- Analyst Decision
- DNTH Strong Buy
- DXPE Buy
- Analyst Count
- DNTH 8
- DXPE 1
- Target Price
- DNTH $46.43
- DXPE $75.00
- AVG Volume (30 Days)
- DNTH 291.2K
- DXPE 129.1K
- Earning Date
- DNTH 11-07-2024
- DXPE 11-04-2024
- Dividend Yield
- DNTH N/A
- DXPE N/A
- EPS Growth
- DNTH N/A
- DXPE 17.97
- EPS
- DNTH N/A
- DXPE 3.87
- Revenue
- DNTH $5,366,000.00
- DXPE $1,738,170,000.00
- Revenue This Year
- DNTH $44.94
- DXPE $8.07
- Revenue Next Year
- DNTH N/A
- DXPE $4.19
- P/E Ratio
- DNTH N/A
- DXPE $17.82
- Revenue Growth
- DNTH 51.41
- DXPE 3.60
- 52 Week Low
- DNTH $6.58
- DXPE $28.82
- 52 Week High
- DNTH $33.77
- DXPE $73.75
- Technical
- Relative Strength Index (RSI)
- DNTH 22.81
- DXPE 72.88
- Support Level
- DNTH $22.19
- DXPE $67.31
- Resistance Level
- DNTH $28.56
- DXPE $71.17
- Average True Range (ATR)
- DNTH 2.02
- DXPE 2.95
- MACD
- DNTH -0.88
- DXPE 0.24
- Stochastic Oscillator
- DNTH 3.38
- DXPE 80.61
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About DXPE DXP Enterprises Inc.
DXP Enterprises Inc is a distributor of products and services to industrial customers in the United States, Canada, Mexico, and Dubai. The company's reportable segments include Service Centers, Innovative Pumping Solutions and Supply Chain Services. It generates maximum revenue from the Service Centers segment. The company offers pumping solutions, supply chain services and maintenance, repair, operating and production services for rotating equipment, bearings and power transmissions, industrial supplies and safety products. DXP Enterprises serves the General Industrial, Oil & Gas, Food & Beverage, Water & Wastewater, Chemical, Transportation, Aerospace & Other.